| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerated versus standard cyclophosphamide, epirubicin and5-fluorouracil or cyclophosphamide, methotrexate and5-fluorouracil: a randomized phase III trial in locally advanced breast cancer
|
Baldini, E.
|
|
|
14 |
2 |
p. 227-232
|
artikel
|
| 2 |
Activation of the receptor protein tyrosine kinase EphB4 in endometrial hyperplasia and endometrial carcinoma
|
Berclaz, G.
|
|
|
14 |
2 |
p. 220-226
|
artikel
|
| 3 |
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors
|
Mavroudis, D.
|
|
|
14 |
2 |
p. 304-312
|
artikel
|
| 4 |
AJCC Cancer Staging Manual, 6th edition
|
Schmoll, H.-J.
|
|
|
14 |
2 |
p. 345
|
artikel
|
| 5 |
Amelioration of docetaxel/cisplatin induced polyneuropathy by α-lipoic acid
|
Gedlicka, C.
|
|
|
14 |
2 |
p. 339-340
|
artikel
|
| 6 |
A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin’s lymphoma
|
Bessell, E.M.
|
|
|
14 |
2 |
p. 258-267
|
artikel
|
| 7 |
A randomized double-blind trial to compare the clinical efficacyof granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis
|
Aapro, M.S.
|
|
|
14 |
2 |
p. 291-297
|
artikel
|
| 8 |
Breast Cancer: a Guide to Detection and Multidisciplinary Therapy
|
Del Mastro, L.
|
|
|
14 |
2 |
p. 345
|
artikel
|
| 9 |
Cancer mortality in Ireland, 1926–1995
|
Boyle, P.
|
|
|
14 |
2 |
p. 323-332
|
artikel
|
| 10 |
Cancer prevalence in Central Europe: the EUROPREVAL Study
|
Lutz, J.M.
|
|
|
14 |
2 |
p. 313-322
|
artikel
|
| 11 |
Chemosensitivity and p53–Bax pathway-mediated apoptosis in patients with uterine cervical cancer
|
Sultana, H.
|
|
|
14 |
2 |
p. 214-219
|
artikel
|
| 12 |
Chemotherapy in gastric cancer: a never ending saga
|
Roth, A.D.
|
|
|
14 |
2 |
p. 175-177
|
artikel
|
| 13 |
Cigarette tar yield and risk of upper digestive tract cancers:case–control studies from Italy and Switzerland
|
Gallus, S.
|
|
|
14 |
2 |
p. 209-213
|
artikel
|
| 14 |
Debate on colorectal cancer screening by faecal occult blood
|
Castiglione, G.
|
|
|
14 |
2 |
p. 342-343
|
artikel
|
| 15 |
Early cardiotoxicity of the CHOP regimen in aggressivenon-Hodgkin’s lymphoma
|
Limat, S.
|
|
|
14 |
2 |
p. 277-281
|
artikel
|
| 16 |
Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923)
|
Tjan-Heijnen, V.C.G.
|
|
|
14 |
2 |
p. 248-257
|
artikel
|
| 17 |
Fatal herpes simplex virus hepatitis complicating chemotherapy with weekly docetaxel
|
Hofer, S.
|
|
|
14 |
2 |
p. 340
|
artikel
|
| 18 |
GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine–cisplatin with vinorelbine–ifosfamide–cisplatin in metastatic non-small-cell lung cancer patientsAnn Oncol 2002; 13: 1853–1861
|
Souquet, P.J.
|
|
|
14 |
2 |
p. 347
|
artikel
|
| 19 |
Idoxifene versus tamoxifen: a randomized comparison in postmenopausal patients with metastatic breast cancer
|
Arpino, G.
|
|
|
14 |
2 |
p. 233-241
|
artikel
|
| 20 |
In this issue
|
|
|
|
14 |
2 |
p. 348
|
artikel
|
| 21 |
Lethal 5-fluorouracil toxicity associated with a novel mutation in the dihydropyrimidine dehydrogenase gene
|
van Kuilenburg, A.B.P.
|
|
|
14 |
2 |
p. 341-342
|
artikel
|
| 22 |
Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma
|
Campbell, J.K.
|
|
|
14 |
2 |
p. 273-276
|
artikel
|
| 23 |
Phase I study of combined radiation, hyperthermia andintra-arterial carboplatin for local recurrence of cervical cancer
|
Tsuda, H.
|
|
|
14 |
2 |
p. 298-303
|
artikel
|
| 24 |
Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IVnon-small-cell lung cancer
|
Bajetta, E.
|
|
|
14 |
2 |
p. 242-247
|
artikel
|
| 25 |
Prediction of response to therapy by biomolecular markers: from the research laboratory to the clinic
|
Ménard, S.
|
|
|
14 |
2 |
p. 178-179
|
artikel
|
| 26 |
Primary systemic treatment of advanced Hodgkin’s disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up
|
Canellos, G.P.
|
|
|
14 |
2 |
p. 268-272
|
artikel
|
| 27 |
Prognostic markers for survival after high-dose chemotherapywith autologous stem-cell transplantation for breast cancer
|
Hensel, M.
|
|
|
14 |
2 |
p. 341
|
artikel
|
| 28 |
Surgical Oncology: Contemporary Principles and Practice
|
Gatzemeier, W.
|
|
|
14 |
2 |
p. 346
|
artikel
|
| 29 |
Table of Contents
|
|
|
|
14 |
2 |
p. v-vi
|
artikel
|
| 30 |
Taxane-induced nail changes: incidence, clinical presentationand outcome
|
Minisini, A.M.
|
|
|
14 |
2 |
p. 333-337
|
artikel
|
| 31 |
The effect of Epstein–Barr virus status on outcome in age- andsex-defined subgroups of patients with advanced Hodgkin’s disease
|
Flavell, K.J.
|
|
|
14 |
2 |
p. 282-290
|
artikel
|
| 32 |
The pharmacological treatment of aggressive fibromatosis: a systematic review
|
Janinis, J.
|
|
|
14 |
2 |
p. 181-190
|
artikel
|
| 33 |
The unknown biology of the unknown primary tumour: a literature review
|
van de Wouw, A.J.
|
|
|
14 |
2 |
p. 191-196
|
artikel
|
| 34 |
Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
|
Cascinu, S.
|
|
|
14 |
2 |
p. 205-208
|
artikel
|
| 35 |
Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer
|
Kruijtzer, C.M.F.
|
|
|
14 |
2 |
p. 197-204
|
artikel
|
Tijdschrift beschrijving